Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-024850
Filing Date
2020-02-25
Accepted
2020-02-25 17:24:35
Documents
1
Period of Report
2020-02-21

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4784
  Complete submission text file 0001104659-20-024850.txt   6236
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850
Business Address
Schwabe Stefan K.F. (Reporting) CIK: 0001557657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 20652241